MARKET

ETTX

ETTX

ENTASIS THERAPEUTICS HOLDINGS INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.81
+0.69
+13.48%
Closed 16:00 09/18 EDT
OPEN
5.37
PREV CLOSE
5.12
HIGH
6.34
LOW
5.20
VOLUME
16.64K
TURNOVER
--
52 WEEK HIGH
13.70
52 WEEK LOW
3.970
MARKET CAP
72.14M
P/E (TTM)
-1.7762
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ETTX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ETTX News

  • Entasis Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
  • GlobeNewswire.09/03 12:00
  • Benzinga's Top Upgrades, Downgrades For August 19, 2019
  • Benzinga.08/19 14:32
  • H.C. Wainwright Initiates Coverage On Entasis Therapeutics Hldg with Buy Rating, Announces $18 Price Target
  • Benzinga.08/19 11:33
  • Entasis Therapeutics reports Q2 results
  • seekingalpha.08/12 16:34

More

Industry

Pharmaceuticals
+0.10%
Pharmaceuticals & Medical Research
-0.05%

Hot Stocks

Name
Price
%Change

About ETTX

Entasis Therapeutics Holdings Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of antibacterial products to treat infections caused by multi-drug resistant Gram-negative bacteria. Its lead product candidate ETX2514 and its other product candidate ETX0282 inhibits bacterial resistance, b-lactamase enzyme. Its pipeline includes ETX2514UL, ETX0282CPDp, Zoliflodacin, and non-beta (b)-lactam inhibitors of the penicillin-binding proteins (NBP) Program. ETX2514SUL is a fixed-dose combination of ETX2514 with sulbactam, as a novel IV antibiotic with broad spectrum b-lactamase coverage. Zoliflodacin as a single dose, oral antibiotic monotherapy. ETX0282CPDP is an oral fixed-dose combination of ETX0282 with cefpodoxime proxetil. The Company is developing a class of antibiotics with its NBP program in which it is designing molecules for optimal activity against the penicillin-binding proteins (PBP) enzymes.
More

Webull offers Entasis Therapeutics Holdings Inc (ETTX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.